FY2029 EPS Estimates for Altimmune Lowered by HC Wainwright
Altimmune, Inc. (NASDAQ:ALT – Free Report) – Equities researchers at HC Wainwright lowered their FY2029 EPS estimates for Altimmune in a research note issued to investors on Monday, March 3rd. HC Wainwright analyst P. Trucchio now forecasts that the company will earn $1.26 per share for the year, down from their prior estimate of $1.30. […]
Altimmune, Inc. (NASDAQ:ALT – Free Report) – Equities researchers at HC Wainwright lowered their FY2029 EPS estimates for Altimmune in a research note issued to investors on Monday, March 3rd. HC Wainwright analyst P. Trucchio now forecasts that the company will earn $1.26 per share for the year, down from their prior estimate of $1.30. […]
